Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2010-07-13
2011-10-11
Schultz, Doug (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S023100, C536S024500, C435S006120, C435S325000, C435S375000
Reexamination Certificate
active
08034794
ABSTRACT:
The ACP1 *A allele provides a means for diagnosing susceptibility of a human subject to hyperlipidemia, especially hyperlipidemia associated with metabolic syndrome, a means for treating, or preventing the onset of, hyperlipidemia and metabolic syndrome, and a means for screening and identifying drugs suitable for use in treating or preventing hyperlipidemia, especially hyperlipidemia associated with metabolic syndrome. Diagnostic kits are also provided.
Bottini Nunzio
Comings David E.
MacMurray James P.
Schultz Doug
Themis Law
LandOfFree
Methods and compositions for acid phosphatase-1 gene inhibition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for acid phosphatase-1 gene inhibition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for acid phosphatase-1 gene inhibition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4274266